Letrozole, a drug taken during the treatment of breast cancer may have some side effects.
The first-ever study conducted by the National Pharmaceutical Pricing Authority (NPPA) on cancer medicines has found huge price variations among different brands of same medicines sold in the country.
'I find, in all this matter, a very unfair treatment... I don't know if I will be able to find the strength and the desire to play tennis again, after all this'
Virginia Fuchs narrowly missed out on qualifying for the Rio Olympics in 2016 and has now set her sights on next year's delayed Tokyo Games.
The National Pharmaceutical Pricing Authority, which regulates the prices of medicines, has identified around 70 anti-cancer drugs, including anti-breast cancer medication Letrozole and anti-blood cancer drug Imatinib, for detailed price analysis.
The 29-year-old former French Open finalist failed the out-of-competition test in February after a urine sample was found to contain letrozole - a substance used in the treatment of breast cancer which is also on the banned drug list of the World Anti-Doping Agency (WADA).
A summary of sports events and persons who made news on Monday
© 2026 Rediff.com - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances